ABOS:NASDAQ, Acumen Pharmaceuticals, Inc.

ABOS stock overview

Acumen Pharmaceuticals, Inc. (ABOS:NASDAQ) closed at $2.27 on October 26, 2026, up 14.65% on the day. The stock trades 36.9% below its 52-week high of $3.60 and 51.3% above its 52-week low of $1.50. Over the past year, it gained 3.2%. Acumen Pharmaceuticals, Inc. is part of the Health Care sector.

Key figures

Price
$2.27
Day change
+14.65%
Volume
1,645,535
Average volume
461,771
Market cap
164M+
52-week range
$1.50 – $3.60
50-day average
$2.51
200-day average
$2.50

Price action over the past year

In 252 trading sessions since October 24, 2025, ABOS closed higher on 122 days (48%). Its best day was January 27, 2026 (+30.77%) and its worst was September 23, 2026 (-13.02%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 2 times.

Recent signals

ABOS news

About Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.

Similar stocks

Find more stocks like ABOS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.